Gross Profit - Prostatype Genomics AB (STO:PROGEN) - Alpha Spread
P

Prostatype Genomics AB
STO:PROGEN

Watchlist Manager
Prostatype Genomics AB
STO:PROGEN
Watchlist
Price: 0.019 SEK -7.32% Market Closed
Market Cap: 18.8m SEK
Have any thoughts about
Prostatype Genomics AB?
Write Note

Prostatype Genomics AB
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Prostatype Genomics AB
Gross Profit Peer Comparison

Comparables:
BIOG B
BONEX
VITR
SOBI
BIOA B

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
P
Prostatype Genomics AB
STO:PROGEN
Gross Profit
kr3.7m
CAGR 3-Years
-2%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Gross Profit
kr950.2m
CAGR 3-Years
20%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Gross Profit
kr678m
CAGR 3-Years
56%
CAGR 5-Years
50%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Gross Profit
kr2B
CAGR 3-Years
30%
CAGR 5-Years
19%
CAGR 10-Years
20%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Gross Profit
kr18.4B
CAGR 3-Years
17%
CAGR 5-Years
17%
CAGR 10-Years
29%
BioArctic AB
STO:BIOA B
Gross Profit
kr565.1m
CAGR 3-Years
144%
CAGR 5-Years
-4%
CAGR 10-Years
N/A

See Also

What is Prostatype Genomics AB's Gross Profit?
Gross Profit
3.7m SEK

Based on the financial report for Dec 31, 2023, Prostatype Genomics AB's Gross Profit amounts to 3.7m SEK.

What is Prostatype Genomics AB's Gross Profit growth rate?
Gross Profit CAGR 3Y
-2%

Over the last year, the Gross Profit growth was 446%. The average annual Gross Profit growth rates for Prostatype Genomics AB have been -2% over the past three years .

Back to Top